Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Comparison of Treatment Algorithms for Nausea/Vomiting in Palliative Cancer Care
NCT03017391Phase 4Unknown
- Sponsor
- Radboud University Medical Center
- Start
- Jan 2017
- Primary completion
- Apr 2018
- Modality
- Small Molecules
01
Overview
Phase 4, randomised, open-label trial of Granisetron Hydrochloride Nasal Spray in nausea ((none)) and Vomiting (2 arms), sponsored by Radboud University Medical Center. Primary endpoint: Numeric Rating Scale for Nausea at 15 days. Status: unknown.
02
Drugs
Granisetron Hydrochloride Nasal Spray
03
Conditions
nausea ((none))Vomiting
Beyond the preview
Go deeper on NCT03017391.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03017391.